These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1312834)

  • 1. Identification of guanidino succinate as a putative endogenous source of the endothelium derived relaxing factor.
    Thomas G; Ramwell PW
    Biochem Biophys Res Commun; 1992 Mar; 183(2):584-9. PubMed ID: 1312834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is guanidino succinate a precursor for nitric oxide synthesis in rat vascular tissue?
    Richard V; Henry JP; Thuillez C
    J Cardiovasc Pharmacol; 1994 Jul; 24(1):50-4. PubMed ID: 7521489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of guanidino compounds on the endothelium-derived relaxing factor inhibitor NG-monomethyl L-arginine.
    Thomas G; Ramwell PW
    J Pharmacol Exp Ther; 1991 Nov; 259(2):490-4. PubMed ID: 1719191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanidino succinic acid is not the endogenous source of endothelium-derived relaxing factor in the porcine isolated splenic artery.
    Lot TY
    Arch Int Pharmacodyn Ther; 1993; 323():62-73. PubMed ID: 8250644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.
    Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Vane JR
    Br J Pharmacol; 1992 Dec; 107(4):1001-7. PubMed ID: 1281716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-arginine induces relaxation of rat aorta possibly through non-endothelial nitric oxide formation.
    Moritoki H; Ueda H; Yamamoto T; Hisayama T; Takeuchi S
    Br J Pharmacol; 1991 Apr; 102(4):841-6. PubMed ID: 1649658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NW-nitro L-arginine benzyl ester, a potent irreversible inhibitor of endothelium dependent relaxation.
    Thomas G; Ramwell PW
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1677-82. PubMed ID: 1930206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of non-arginine compounds with the endothelium-derived relaxing factor inhibitor, NG-monomethyl L-arginine.
    Thomas G; Ramwell PW
    J Pharmacol Exp Ther; 1992 Feb; 260(2):676-9. PubMed ID: 1310739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine.
    Frew JD; Paisley K; Martin W
    Br J Pharmacol; 1993 Nov; 110(3):1003-8. PubMed ID: 7507774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-dependent vasorelaxation evoked by desmopressin and involvement of nitric oxide in rat aorta.
    Yamada K; Nakayama M; Nakano H; Mimura N; Yoshida S
    Am J Physiol; 1993 Feb; 264(2 Pt 1):E203-7. PubMed ID: 8383436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta.
    Vetrovsky P; Boucher JL; Schott C; Beranova P; Chalupsky K; Callizot N; Muller B; Entlicher G; Mansuy D; Stoclet JC
    J Pharmacol Exp Ther; 2002 Nov; 303(2):823-30. PubMed ID: 12388669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.
    Fasehun OA; Gross SS; Rubin LE; Jaffe EA; Griffith OW; Levi R
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1348-53. PubMed ID: 2175803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta.
    Zembowicz A; Hatchett RJ; Jakubowski AM; Gryglewski RJ
    Br J Pharmacol; 1993 Sep; 110(1):151-8. PubMed ID: 7693274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
    Komas N; Lugnier C; Stoclet JC
    Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide mediated endothelium-dependent relaxation induced by glibenclamide in rat isolated aorta.
    Chan W; Yao X; Ko W; Huang Y
    Cardiovasc Res; 2000 Apr; 46(1):180-7. PubMed ID: 10727666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nitric oxide and guanosine 3',5'-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries.
    Liu SF; Crawley DE; Rohde JA; Evans TW; Barnes PJ
    Br J Pharmacol; 1992 Nov; 107(3):861-6. PubMed ID: 1335345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta.
    Moritoki H; Hisayama T; Takeuchi S; Miyano H; Kondoh W
    Br J Pharmacol; 1992 Sep; 107(1):196-201. PubMed ID: 1358382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.
    Moore PK; al-Swayeh OA; Chong NW; Evans RA; Gibson A
    Br J Pharmacol; 1990 Feb; 99(2):408-12. PubMed ID: 2328404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of endothelium on induction of the L-arginine-nitric oxide pathway in rat aortas.
    Fleming I; Gray GA; Stoclet JC
    Am J Physiol; 1993 Apr; 264(4 Pt 2):H1200-7. PubMed ID: 8386480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor.
    Stork AP; Cocks TM
    Br J Pharmacol; 1994 Dec; 113(4):1099-104. PubMed ID: 7889260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.